2004
DOI: 10.1128/aac.48.6.2288-2291.2004
|View full text |Cite
|
Sign up to set email alerts
|

Posaconazole Therapy of Disseminated Phaeohyphomycosis in a Murine Model

Abstract: Immunocompetent (nu/+) and athymic (nu/nu) BALB/c mice were infected intravenously with Wangiella dermatitidis and treated with posaconazole. Posaconazole reduced the counts in tissues and prolonged survival. Of particular interest, posaconazole reduced the counts of this neurotropic pathogen in the brain

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
24
0

Year Published

2006
2006
2018
2018

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 42 publications
(25 citation statements)
references
References 23 publications
1
24
0
Order By: Relevance
“…Based on the data presented in the current study, POS and echinocandins were the antimycotics with the best overall activity, having broad-spectrum activity against both thermotolerant and mesophilic species. The apparently good penetration of POS into the central nervous system (CNS), with the MIC falling well below the serum levels achievable with standard dosing regimens (38), combined with excellent in vitro data (39) and activity in animal models (40)(41)(42)(43), supports the use of POS for difficult-to-treat disseminated brain infections. In the clinical setting, POS has been used successfully in cases of cerebral and disseminated phaeohyphomycosis (44,45).…”
Section: Discussionmentioning
confidence: 96%
“…Based on the data presented in the current study, POS and echinocandins were the antimycotics with the best overall activity, having broad-spectrum activity against both thermotolerant and mesophilic species. The apparently good penetration of POS into the central nervous system (CNS), with the MIC falling well below the serum levels achievable with standard dosing regimens (38), combined with excellent in vitro data (39) and activity in animal models (40)(41)(42)(43), supports the use of POS for difficult-to-treat disseminated brain infections. In the clinical setting, POS has been used successfully in cases of cerebral and disseminated phaeohyphomycosis (44,45).…”
Section: Discussionmentioning
confidence: 96%
“…Nevertheless, low MIC values of POS (Ő…1 g/ml) and VRC (Ő…2 g/ml) were recorded in 96% and 95% of isolates. Previously, Ben Ami et al reported that POS had low MICs against MF and is also effective in an animal model of PHM (2,29). Also, echinocandins had high MECs (Ő†2 g/ml) in 39% of isolates, mainly among the genera Medicopsis, Exophiala, and Cladophialophora.…”
Section: Discussionmentioning
confidence: 96%
“…Al-Abdely et al found posaconazole to be more effective than amphotericin B or itraconazole in murine models of central nervous system infection with R. mackenziei and C. bantiana (14,15). Posaconazole was also found to be effective in a model of disseminated E. dermatiditis infection (301). In another murine model of C. bantiana infection, posaconazole and flucytosine improved survival alone, though the combination of posaconazole, flucytosine, and micafungin yielded the greatest benefit (481).…”
Section: Animal Models Of Infectionmentioning
confidence: 99%